IBIO CIK: 1420720

iBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−37.5
FY23:
−30.4
FY24:
−18.6
FY25:
−15.3
FY26:
−23.2
Change from FY22 to FY26
millions USD
FY22:
−5.13
FY23:
7.01
FY24:
0.91
FY25:
0.74
FY26:
−32.0
Change from FY22 to FY26
millions USD
FY22:
−6.13
FY23:
2.30
FY24:
24.5
FY25:
8.93
FY26:
103
millions USD
FY22:
−48.7
FY23:
−21.1
FY24:
6.85
FY25:
−5.63
FY26:
47.8
(positive)
Change from FY22 to FY26
millions USD
FY22:
−44.8
FY23:
−36.2
FY24:
−18.8
FY25:
−15.3
FY26:
−23.8

All amounts in millions USD Data source:SEC EDGAR